An in-depth look to Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock operating, investing, and financing activities

CYCCP free cash flow for Q1 24 is -483 k USD. For 2023, CYCCP free cash flow was -16.12 M USD and operating cash flow was -16.11 M USD.